Cancer - Advances, Knowledge, Integrative & Holistic Treatments
19.3K views | +1 today
Follow
Cancer - Advances, Knowledge, Integrative & Holistic Treatments
Your new post is loading...
Your new post is loading...
Scooped by Graham Player Ph.D.
Scoop.it!

Breast Cancer Classification Varies According to Hormone Receptor Status and HER2 Gene.

Breast Cancer Classification Varies According to Hormone Receptor Status and HER2 Gene. | Cancer - Advances, Knowledge, Integrative & Holistic Treatments | Scoop.it
(HealthDay)—Breast cancer isn't the same for every woman, even at the cellular level, according to a new statement from four major medical groups focused on the disease.
Graham Player Ph.D.'s insight:

A report issued by the American Cancer Society, the U.S. Centers for Disease Control and Prevention, the U.S. National Cancer Institute, and the North American Association of Central Cancer Registries, classifies breast cancers based on four molecularly defined subtypes according to their hormone receptor (HR) status and a tumor cell's activity around the HER2 gene.

The four tumor types, which respond differently to treatment and have different survival rates, are:
- Luminal A (HR+/HER2-),
- Luminal B (HR+/HER2+),
- HER2-enriched (HR-/HER2+), and
- Triple negative (HR-/HER2-).

Cancer registries across the United States are now recording these breast cancer subtypes.

Dr. Charles Shapiro, director of Translational Breast Cancer Research at the Tisch Cancer Institute at Mount Sinai in New York City, comments that "the biology of these subtypes is of critical importance to selecting the most effective treatments for breast cancer.”

more...
No comment yet.
Rescooped by Graham Player Ph.D. from Longevity science
Scoop.it!

New Device to Test for Cancer

New Device to Test for Cancer | Cancer - Advances, Knowledge, Integrative & Holistic Treatments | Scoop.it

 

Fast, precise, inexpensive cancer-cell testing device (credit: EPFL)

 

Among a significant percentage of patients, the risk of metastasis of cancer is particularly expressed by the presence of an abnormal amount of protein HER2 on the surface of cancer cells.

 


Via Ray and Terry's
Graham Player Ph.D.'s insight:

A new diagnostic device has been developed that tests for the presence of a protein on the surface of cancer cells. The test can be done in just a few minutes compared to the current lengthy traditional method.

more...
No comment yet.